Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Article in Nature Communications (February 2024)
The most recent citing publications are shown below. View all 77 publications that cite this research output on Dimensions.
Article in Nature Communications (February 2024)
Article in Virologica Sinica (November 2023)
Article in BMC Pharmacology and Toxicology (October 2023)